Bridge City Capital’s iRadimed IRMD Stock Holding History

Bridge City Capital’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.99M	Buy	72,573 +1,719	+2%	+$172K	1.94%	12
2025 Q4	$6.89M	Buy	70,854 +11,509	+19%	+$987K	2.03%	7
2025 Q3	$4.22M	Sell	59,345 -833	-1%	-$55.5K	1.13%	30
2025 Q2	$3.6M	Sell	60,178 -978	-2%	-$53.6K	1.01%	34
2025 Q1	$3.21M	Sell	61,156 -743	-1%	-$41.7K	0.96%	46
2024 Q4	$3.4M	Buy	61,899 +462	+0.8%	+$24.3K	0.91%	46
2024 Q3	$3.09M	Buy	61,437 +7,106	+13%	+$328K	0.85%	50
2024 Q2	$2.39M	Buy	54,331 +12,148	+29%	+$517K	0.8%	51
2024 Q1	$1.86M	Buy	42,183 +8,034	+24%	+$355K	0.68%	76
2023 Q4	$1.62M	Buy	34,149 +5,977	+21%	+$251K	0.63%	76
2023 Q3	$1.25M	Buy	+28,172	New	+$1.31M	0.63%	76

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bridge City Capital's IRMD Position: Q1 2026 in Review

Bridge City Capital increased its iRadimed (IRMD) stake by 2.4% in Q1 2026, buying an estimated $172K and bringing the position to 72,573 shares worth $6.99M. The position accounts for 1.94% of the portfolio, ranked #12.

Bridge City Capital first reported a position in IRMD in Q3 2023 and has held it in 11 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Bridge City Capital held 72,573 shares of iRadimed worth $6.99M as of Q1 2026.
Bridge City Capital bought 1,719 iRadimed shares in Q1 2026, an estimated $172K.
iRadimed made up 1.94% of Bridge City Capital's portfolio in Q1 2026, its #12 holding.
Bridge City Capital first reported a position in iRadimed in Q3 2023 and has held it in 11 quarters since.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Bridge City Capital's 13F filing for Q1 2026, filed 13 May 2026.